Found Reviews: Pricing, Support Quality, and Are They Worth It

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found charges $289/month for compounded semaglutide and $359/month for compounded tirzepatide on its standard month-to-month cash plans. PlexusDx charges $189/month for semaglutide and $289/month for tirzepatide on equivalent month-to-month terms—a $100/month and $70/month cash difference, respectively. Found offers a separate insurance track ($99–$199/month billed annually or monthly, plus medication copays averaging ~$30) that delivers lower total cost when insurance covers your GLP-1, an option PlexusDx does not provide. Found also bundles a proprietary app with 24/7 care-team access, personalized coaching, and an AI health companion; PlexusDx includes asynchronous clinical messaging and straightforward medication delivery without a dedicated app or structured coaching program. Trustpilot shows Found at 4.1 stars across ~732 reviews (captured September 4, 2026). If you have insurance coverage for GLP-1 medications and want continuous app-based support, Found's insurance track will likely cost less than any cash program. If you are paying cash month-to-month and prefer transparent, lower baseline pricing without mandatory app bundles, PlexusDx delivers the same compounded medications for $840–$1,200 less per year.

At-a-glance comparison: Found vs PlexusDx

Sources: Found website captured July 20, 2026 and September 4, 2026; PlexusDx product pages; Trustpilot captured September 4, 2026.

Like-for-like pricing: Found vs PlexusDx

Found bills its cash plans every four weeks, producing 13 billing cycles per year. PlexusDx bills monthly, for 12 cycles per year. To make annual costs comparable, we multiply Found's per-cycle rate by 13 and PlexusDx's monthly rate by 12.

Month-to-month cash (no commitment)

• Found semaglutide: $289/cycle × 13 = $3,757/year
• PlexusDx semaglutide: $189/month × 12 = $2,268/year
• Cash difference: $1,489/year ($124/month average), favoring PlexusDx

• Found tirzepatide: $359/cycle × 13 = $4,667/year
• PlexusDx tirzepatide: $289/month × 12 = $3,468/year
• Cash difference: $1,199/year ($100/month average), favoring PlexusDx

Prepaid term plans (lower committed-term rates)

Found offers 3-, 6-, and 12-month prepaid cash plans with reduced per-month effective rates. PlexusDx offers 3- and 6-month prepaid plans. Found's 12-month semaglutide cash plan totals $2,028 upfront (a $169/month equivalent, labeled as prepaid), captured July 20, 2026. PlexusDx's longest commitment (6-month) is $149/month for semaglutide, or $1,788/year (our calculation: $149 × 12 months). Found's 12-month prepaid total ($2,028) is $240/year higher than PlexusDx's 6-month rate extended to 12 months.

For tirzepatide, Found's 12-month prepaid plan is captured at a $239/month effective rate (billed every 48 weeks), totaling $2,868/year (our calculation: $239 × 12), captured July 20, 2026. PlexusDx's 6-month tirzepatide rate is $249/month, or $2,988/year extended to 12 months (our calculation), $120/year higher than Found's 12-month prepaid.

Key takeaway: Found's 12-month prepaid semaglutide cash plan costs more annually than PlexusDx's 6-month rate. Found's 12-month prepaid tirzepatide plan costs slightly less annually than PlexusDx's 6-month rate, but the difference is modest ($120/year, or $10/month).

Insurance track (Found only)

Found operates a separate insurance pathway for patients whose health plans cover GLP-1 medications for weight loss. This track charges $199/month for the care plan on a month-to-month basis, or $1,188 upfront for 12 months (a $99/month effective rate, labeled as prepaid), captured September 4, 2026. Medication is billed through insurance; typical member copays are approximately $30, captured September 4, 2026. Over 12 months, the insurance track costs approximately $1,548/year (our calculation: $1,188 plan + $30 copay × 12 visits), significantly below any cash program when insurance covers your medication.

PlexusDx does not offer an insurance billing pathway. If your health plan covers compounded or branded GLP-1 medications for weight loss and you qualify clinically, Found's insurance track delivers lower total cost than PlexusDx cash pricing.

Support quality and service model

Found bundles a proprietary mobile app with 24/7 access to a care team, personalized care plans built by licensed clinicians, an AI health companion called Aimee, and a member community (captured July 20 and September 4, 2026). This structured coaching layer is included in Found's plan price and differentiates the service from medication-focused telehealth providers. Trustpilot shows Found at 4.1 stars across approximately 732 reviews, captured September 4, 2026. The review volume and rating suggest generally positive patient experience, though the evidence packet did not capture specific negative themes or attributable excerpts from indexed results.

PlexusDx includes asynchronous clinical messaging with licensed providers and does not offer a dedicated app, structured coaching program, or community features. Patients receive medication with provider oversight but do not have 24/7 care-team access or personalized behavior-change tools beyond standard clinical consultation.

If app-based support, continuous coaching access, and community engagement are important to your weight-management strategy, Found's bundled service model justifies a portion of its higher cash price. If you prefer straightforward medication access without mandatory app engagement, PlexusDx's lower baseline cost reflects a leaner service architecture.

Medication formats and branded options

Found's cash and insurance plans include compounded semaglutide and tirzepatide injections at the prices listed above (captured July 20 and September 4, 2026). Found also lists branded GLP-1 medications—Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Victoza, and Foundayo (orforglipron)—as available, but these are billed separately and not included in the base plan price (captured September 4, 2026). The evidence does not document pricing for branded medications or confirm availability of compounded oral formulations through Found.

PlexusDx offers compounded injectable semaglutide ($189/month month-to-month), compounded injectable tirzepatide ($289/month month-to-month), compounded oral semaglutide ($289/month month-to-month), and compounded oral tirzepatide ($349/month month-to-month), plus a microdose GLP-1 maintenance protocol ($129/month month-to-month). PlexusDx does not stock branded medications.

If you want the option to switch between compounded and branded medications within one provider, Found supports that flexibility (at additional cost). If you want oral compounded options alongside injectables, PlexusDx documents those explicitly. If you are committed to standard compounded injections, both providers deliver the same active compounds from licensed 503A compounding pharmacies.

Billing cadence and annual cycle count

Found bills cash plans every four weeks, resulting in 13 billing events per year (captured July 20, 2026). PlexusDx bills monthly, for 12 events per year. This structural difference means Found's stated per-cycle price must be multiplied by 13 to yield an annual total, while PlexusDx's monthly price is multiplied by 12. The four-week cycle is common in subscription consumer services but less intuitive for patients expecting 12-month calendar billing. When comparing programs, always normalize to a 12-month period using the correct cycle count.

Cancellation and refund terms

Found offers a full refund if you are not clinically eligible for GLP-1 therapy and allows you to cancel anytime in the Found app (captured July 20, 2026). The evidence does not specify refund terms for patients who start treatment and then discontinue, or for prepaid multi-month plans canceled mid-term.

PlexusDx operates on month-to-month or prepaid terms with no long-term contract lock-in. Patients can discontinue at the end of any billing period. Prepaid plans are non-refundable once the term begins, consistent with standard telehealth prepayment policies.

Choose Found if…

• Your health insurance covers GLP-1 medications for weight loss, and you want a provider that bills insurance directly (Found's insurance track at $99–$199/month plus copay will likely cost less than any cash program).
• You value continuous app-based support, 24/7 care-team access, personalized coaching, and community features as part of your weight-management strategy.
• You prefer the option to access branded GLP-1 medications (Ozempic, Wegovy, Zepbound, etc.) through the same provider, even if billed separately.
• You are willing to commit to a 12-month prepaid cash plan to lower your effective monthly rate and do not need the flexibility of month-to-month cancellation.
• You want a provider with established review volume and a 4.1-star Trustpilot rating reflecting generally positive patient experience.

Where PlexusDx fits

• You are paying cash and want the lowest baseline month-to-month price: $189/month for semaglutide and $289/month for tirzepatide, $100 and $70/month below Found's standard cash rates respectively.
• You prefer straightforward medication delivery with asynchronous clinical oversight and do not need a dedicated app or structured coaching program.
• You want access to oral compounded GLP-1 options (oral semaglutide $289/month, oral tirzepatide $349/month) or a microdose maintenance protocol ($129/month) that Found does not document.
• You value transparent, calendar-month billing (12 cycles/year) over four-week cycles (13 cycles/year).
• You want the flexibility of 3- or 6-month prepaid terms without committing to a full year, and you want those lower rates to remain below competitors' longer-term prepaid equivalents (PlexusDx 6-month semaglutide at $149/month = $1,788/year, below Found's 12-month prepaid semaglutide total of $2,028/year).

Methodology and freshness

This comparison uses standard ongoing month-to-month rates and prepaid totals only, verified at the dates shown. Found's pricing was captured from the Found website on July 20, 2026 and September 4, 2026. PlexusDx pricing was captured from PlexusDx product pages on September 4, 2026. Trustpilot data for Found was captured September 4, 2026. Annual cost calculations are ours: Found's per-cycle rate × 13 cycles/year; PlexusDx's monthly rate × 12 months/year; prepaid totals extended to 12 months where applicable. All figures reflect cash pay unless explicitly labeled as insurance track. Prices may change; confirm current rates at checkout before committing to any program.

Frequently Asked Questions

Does Found's insurance track work with all health plans?

No. Found's insurance track requires that your specific health plan covers GLP-1 medications for weight loss. Coverage varies by insurer, plan type, and state. Found verifies eligibility during intake. If your plan does not cover GLP-1 therapy, you would use Found's cash pay option instead.

Why does Found charge every four weeks instead of monthly?

Four-week billing cycles are common in subscription services and align medication shipments with a fixed 28-day interval. The trade-off is 13 billing events per year instead of 12, increasing the annual cost by one additional cycle compared to calendar-month billing. Always multiply Found's per-cycle rate by 13 when calculating annual totals.

Can I switch from Found's cash plan to the insurance track mid-year?

The evidence does not document Found's policy on switching between cash and insurance tracks after enrollment. Contact Found's support team to confirm whether mid-term plan changes are permitted and whether prepaid balances transfer or refund when switching tracks.

Does PlexusDx offer an app or coaching program I can add later?

No. PlexusDx provides asynchronous clinical messaging with licensed providers and does not offer a proprietary app, structured coaching, or community features. The service model is medication-focused with provider oversight, not behavior-change coaching. If you want app-based support, you would need to use a separate coaching service or choose a provider like Found that bundles those features.

Are Found's compounded medications the same as PlexusDx's compounded medications?

Both Found and PlexusDx work with licensed 503A compounding pharmacies to prepare semaglutide and tirzepatide injections. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounding quality and sourcing can vary across pharmacies; both providers state they work with licensed facilities, but neither publicly discloses specific pharmacy partners or third-party testing protocols.

Sources

• Found website, pricing pages, captured July 20, 2026 and September 4, 2026
• PlexusDx product pages, captured September 4, 2026
• Trustpilot profile for Found, captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.